Pre‐hospital notification reduced the door‐to‐needle time for iv t‐PA in acute ischaemic stroke
暂无分享,去创建一个
S. Y. Kim | S. Y. Lee | S. Y. Kim | J. Cha | H. Bae | H. Bae | S. K. Kim | M. Kang | Y. S. Lee | S. K. Kim | Yong Seok Lee
[1] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[2] Hyo Suk Nam,et al. Improved Time Intervals by Implementation of Computerized Physician Order Entry-Based Stroke Team Approach , 2006, Cerebrovascular Diseases.
[3] Jae Hyeon Park,et al. Analysis of 10,811 Cases with Acute Ischemic Stroke from Korean Stroke Registry: Hospital-Based Multicenter Prospective Registration Study , 2006 .
[4] J. Martí-Fàbregas,et al. Benefits of a Prehospital Stroke Code System , 2005, Cerebrovascular Diseases.
[5] P. Marx,et al. Intravenous tPA for Ischemic Stroke: Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience , 2001, Stroke.
[6] J. Grotta,et al. Early stroke treatment associated with better outcome: the ninds rt-pa stroke study , 2000, Neurology.
[7] W. Rosamond,et al. Prehospital and Emergency Department Delays After Acute Stroke: The Genentech Stroke Presentation Survey , 2000, Stroke.
[8] J. Grotta,et al. Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial , 2000, Stroke.
[9] A. Furlan,et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. , 2000, JAMA.
[10] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[11] R. Luepker,et al. Delayed Hospital Arrival for Acute Stroke: The Minnesota Stroke Survey , 1998, Annals of Internal Medicine.
[12] J. Rothrock,et al. Implementation of a stroke code system in Mobile, Alabama. Diagnostic and therapeutic yield. , 1997, Stroke.
[13] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[14] A. Dávalos,et al. [Latent periods in attending patients with acute cerebrovascular disease. A multicenter study]. , 1996, Revista de neurologia.
[15] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[16] A. Dávalos,et al. Delay in Neurological Attention and Stroke Outcome , 1995 .
[17] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[18] J. Broderick,et al. Time of hospital presentation in patients with acute stroke. , 1993, Archives of internal medicine.
[19] T. Tomsick. Intravenous thrombolysis for acute ischemic stroke. , 2004, Journal of vascular and interventional radiology : JVIR.
[20] Robert D. Brown,et al. vator for acute ischemic stroke : feasibility , safety , and efficacy in the first year of clinical practice , 1999 .
[21] P. Wester,et al. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study.Seek- Medical-Attention-in-Time Study Group. , 1999, Stroke.
[22] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[23] J. Grotta,et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.
[24] J. Rothrock,et al. Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. , 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.